Protokinetix Stock Today
PKTX Stock | USD 0.01 0.0008 9.88% |
Performance1 of 100
| Odds Of DistressLess than 42
|
Protokinetix is trading at 0.0089 as of the 2nd of December 2024; that is 9.88 percent increase since the beginning of the trading day. The stock's open price was 0.0081. Protokinetix has about a 42 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Protokinetix are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of October 2024 and ending today, the 2nd of December 2024. Click here to learn more.
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins or anti-aging glycoproteins . ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio. The company has 316.85 M outstanding shares. More on Protokinetix
Moving together with Protokinetix Pink Sheet
0.71 | NVO | Novo Nordisk AS | PairCorr |
0.68 | NONOF | Novo Nordisk AS | PairCorr |
0.66 | REGN | Regeneron Pharmaceuticals | PairCorr |
Moving against Protokinetix Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Protokinetix Pink Sheet Highlights
Chairman, CEO and Pres | Clarence Smith |
Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Protokinetix [PKTX] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Protokinetix's market, we take the total number of its shares issued and multiply it by Protokinetix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Protokinetix conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 316.85 M outstanding shares.
Protokinetix currently holds about 18.83 K in cash with (889.89 K) of positive cash flow from operations.
Check Protokinetix Probability Of Bankruptcy
Ownership AllocationProtokinetix owns a total of 316.85 Million outstanding shares. Protokinetix has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Protokinetix Ownership Details
Protokinetix Risk Profiles
Mean Deviation | 9.39 | |||
Semi Deviation | 11.35 | |||
Standard Deviation | 14.28 | |||
Variance | 203.82 |
Protokinetix Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Protokinetix without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Additional Tools for Protokinetix Pink Sheet Analysis
When running Protokinetix's price analysis, check to measure Protokinetix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protokinetix is operating at the current time. Most of Protokinetix's value examination focuses on studying past and present price action to predict the probability of Protokinetix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protokinetix's price. Additionally, you may evaluate how the addition of Protokinetix to your portfolios can decrease your overall portfolio volatility.